August 19, 2021
Dear Advocates,
The COVID-19 pandemic has highlighted the importance and complexities of advancing critically needed research as part of an international response to public health emergencies.
Good Participatory Practice (GPP) is essential to this research agenda. GPP is a framework to promote meaningful and sustainable relationships throughout the lifecycle of clinical research.
AVAC is offering a 10-week online course—running from September 6 to November 19—to provide community engagement coordinators or managers, advocates working with communities, and research implementers with a foundational knowledge of the
Good Participatory Practice (GPP) Guidelines, a deeper understanding of how to build sustainable relationships with community and broader stakeholders. New to this offering, one of the modules focuses on the value of stakeholder engagement in clinical trials in the context of an emerging epidemic or pandemic, such as COVID-19 or Ebola.
The course draws from lessons learned from various infectious disease areas, the rollout of new interventions, and COVID-19 research to date. Insights from these efforts will be used to foster participants’ capacity to develop quick and responsive stakeholder engagement in research and beyond.
Participants will benefit from a combination of interactive online modules, video webinars, written assignments, discussion forums, and a suite of specially curated resources. Learners will customize the course topics and resources that meet their needs. Global GPP experts will discuss high-impact models of engagement and help synthesize theory into easy-to-understand actionable steps. Participants will spend 2-4 hours per week on the course, culminating in a GPP action plan that aligns with their specific work and role in the field.
Join the hundreds of participants—from more than 20 countries since 2014—who have participated in the GPP online course!
Applications are due
by August 31st and notifications will be made in September.
Apply to participate in the course today!
As always,
please reach out with any questions.
Best,
AVAC
